• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚合物相关的非病毒 siRNA 递送中的脱靶效应。

Polymer-related off-target effects in non-viral siRNA delivery.

机构信息

Department of Pharmaceutics and Biopharmacy, Philipps Universität Marburg, Ketzerbach 63, 35032 Marburg, Germany.

出版信息

Biomaterials. 2011 Mar;32(9):2388-98. doi: 10.1016/j.biomaterials.2010.11.081. Epub 2010 Dec 22.

DOI:10.1016/j.biomaterials.2010.11.081
PMID:21183213
Abstract

Since off-target effects in non-viral siRNA delivery are quite common but not well understood, in this study various polymer-related effects observed in transfection studies were described and their mechanisms of toxicity were investigated. A variety of stably luciferase-expressing cell lines was compared concerning polymer-mediated effects after transfection with polyplexes of siRNA and poly(ethylene imine) (PEI) or poly(ethylene glycol)-grafted PEI (PEG-PEI). Cell viability, LDH release, gene expression profiles of apoptosis-related genes and promoter activation were investigated. Interestingly, PEG-PEI, which is generally better tolerated than PEI, was found to activate apoptosis in a cell line- and concentration-dependent manner. While both polymers showed sigmoidal dose-response of cell viability in L929 cells (IC(50)(PEI) = 6 μg/ml, IC(50)(PEG-PEI) = 11 μg/ml), H1299/Luc cells exhibited biphasic dose-response for PEG-PEI and stronger apoptosis at 2 μg/ml than at 20 μg/ml PEG-PEI, as shown in TUNEL assays. Gene expression profiling confirmed that H1299/Luc cells underwent apoptosis via thousand-fold activation of TNF receptor-associated factors. Additionally, it was demonstrated that NFkB-mediated CMV promoter activation in stably transfected cells can lead to increased target gene levels after transfection instead of siRNA-mediated knockdown. With these results, polymeric vectors were shown not to be inert substances. Therefore, alterations in gene expression caused by the delivery agent must be known to correctly interpret gene-silencing experiments, to understand the mechanisms of off-target effects, and most of all to further develop vectors with reduced side effects. Taking these observations into account, one established cell line was eventually identified to be suitable for RNAi experiments. As shown by these experiments, materials that have been used for many years can elicit unexpected off-target effects. Therefore, non-viral vectors must be screened for several levels of toxicity to make them promising candidates.

摘要

由于非病毒 siRNA 递送中的脱靶效应相当常见,但尚未得到很好的理解,因此在本研究中,描述了转染研究中观察到的各种与聚合物相关的效应,并研究了其毒性机制。比较了各种稳定表达荧光素酶的细胞系,研究了用 siRNA 和聚(亚乙基亚胺)(PEI)或聚乙二醇接枝的 PEI(PEG-PEI)的多聚物转染后,与聚合物相关的效应。研究了细胞活力、LDH 释放、凋亡相关基因的基因表达谱和启动子激活。有趣的是,通常比 PEI 更耐受的 PEG-PEI 被发现以细胞系和浓度依赖的方式激活凋亡。虽然两种聚合物在 L929 细胞中均表现出细胞活力的 S 形剂量反应(PEI 的 IC(50)= 6 μg/ml,PEG-PEI 的 IC(50)= 11 μg/ml),但 H1299/Luc 细胞对 PEG-PEI 表现出双相剂量反应,与 20 μg/ml 的 PEG-PEI 相比,2 μg/ml 的 PEG-PEI 表现出更强的凋亡,如 TUNEL 测定所示。基因表达谱分析证实,H1299/Luc 细胞通过 TNF 受体相关因子的千倍激活而发生凋亡。此外,还证明了稳定转染细胞中 NFkB 介导的 CMV 启动子激活可导致转染后靶基因水平增加,而不是 siRNA 介导的下调。有了这些结果,聚合物载体就不是惰性物质了。因此,必须了解递送剂引起的基因表达改变,以便正确解释基因沉默实验,了解脱靶效应的机制,最重要的是,进一步开发副作用较小的载体。考虑到这些观察结果,最终确定了一种已建立的细胞系适合进行 RNAi 实验。正如这些实验所示,多年来一直使用的材料可能会产生意想不到的脱靶效应。因此,必须对非病毒载体进行多种毒性水平的筛选,以使其成为有前途的候选物。

相似文献

1
Polymer-related off-target effects in non-viral siRNA delivery.聚合物相关的非病毒 siRNA 递送中的脱靶效应。
Biomaterials. 2011 Mar;32(9):2388-98. doi: 10.1016/j.biomaterials.2010.11.081. Epub 2010 Dec 22.
2
Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.壳聚糖接枝-(PEI-β-环糊精)共聚物及其超分子聚乙二醇化用于 DNA 和 siRNA 的递送。
Biomaterials. 2011 Nov;32(32):8328-41. doi: 10.1016/j.biomaterials.2011.07.038. Epub 2011 Aug 15.
3
Low molecular weight linear polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine triblock copolymers: synthesis, characterization, and in vitro gene transfer properties.低分子量线性聚乙烯亚胺-b-聚(乙二醇)-b-聚乙烯亚胺三嵌段共聚物:合成、表征及体外基因转移特性
Biomacromolecules. 2005 Nov-Dec;6(6):3440-8. doi: 10.1021/bm050505n.
4
Synthesis of a new potential biodegradable disulfide containing poly(ethylene imine)-poly(ethylene glycol) copolymer cross-linked with click cluster for gene delivery.合成一种新型潜在可生物降解的含二硫键的聚(亚乙基亚胺)-聚(乙二醇)共聚物,与点击簇交联用于基因传递。
Int J Pharm. 2011 Jun 15;411(1-2):197-205. doi: 10.1016/j.ijpharm.2011.03.038. Epub 2011 Mar 23.
5
Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes.聚乙二醇链长对聚乙烯亚胺接枝聚乙二醇嵌段共聚物/小干扰RNA复合物理化性质和生物学性质的影响
Bioconjug Chem. 2006 Sep-Oct;17(5):1209-18. doi: 10.1021/bc060129j.
6
Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes.使用靶向细胞肽偶联的多聚物的前列腺癌细胞特异性 VEGF siRNA 递释系统。
J Drug Target. 2009 May;17(4):311-7. doi: 10.1080/10611860902767232.
7
Brush-shaped polycation with poly(ethylenimine)-b-poly(ethylene glycol) side chains as highly efficient gene delivery vector.具有聚(亚乙基亚胺)-b-聚(乙二醇)侧链的刷状聚阳离子作为高效基因传递载体。
Int J Pharm. 2010 Jun 15;392(1-2):118-26. doi: 10.1016/j.ijpharm.2010.03.043. Epub 2010 Mar 25.
8
Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate.与反义寡脱氧核苷酸、合成小干扰RNA以及与聚乙二醇化聚乙烯亚胺-叶酸共轭物复合的小干扰RNA质粒相比,对靶向特异性绿色荧光蛋白基因沉默效率的评估。
Bioconjug Chem. 2006 Jan-Feb;17(1):241-4. doi: 10.1021/bc050289f.
9
PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice.聚乙烯亚胺的聚乙二醇化在静脉注射小鼠后,在体内条件下以剂量依赖的方式影响其与质粒DNA复合物的稳定性。
Bioconjug Chem. 2005 Jul-Aug;16(4):785-92. doi: 10.1021/bc049743q.
10
In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.各种聚乙烯亚胺(-聚乙二醇)/小干扰RNA复合物的体内药代动力学、组织分布及潜在机制
Toxicol Appl Pharmacol. 2009 Apr 1;236(1):97-108. doi: 10.1016/j.taap.2009.01.014. Epub 2009 Jan 29.

引用本文的文献

1
Aerosol Inhalation of Gene Delivery Therapy for Pulmonary Diseases.气溶胶吸入基因传递疗法治疗肺部疾病。
Biomolecules. 2024 Jul 25;14(8):904. doi: 10.3390/biom14080904.
2
Growth factors and growth factor gene therapies for treating chronic wounds.用于治疗慢性伤口的生长因子及生长因子基因疗法。
Bioeng Transl Med. 2023 Dec 28;9(3):e10642. doi: 10.1002/btm2.10642. eCollection 2024 May.
3
The current status of various preclinical therapeutic approaches for tendon repair.各种腱修复的临床前治疗方法的现状。
Ann Med. 2024 Dec;56(1):2337871. doi: 10.1080/07853890.2024.2337871. Epub 2024 May 13.
4
Pulmonary siRNA Delivery with Sophisticated Amphiphilic Poly(Spermine Acrylamides) for the Treatment of Lung Fibrosis.复杂两亲性聚(多聚精胺丙烯酰胺)介导的肺部 siRNA 递送来治疗肺纤维化。
Small. 2024 May;20(22):e2308775. doi: 10.1002/smll.202308775. Epub 2023 Dec 21.
5
Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges.基于小干扰 RNA(siRNA)的抗病毒治疗应用:原理、潜力和挑战。
J Biomed Sci. 2023 Oct 16;30(1):88. doi: 10.1186/s12929-023-00981-9.
6
A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics.siRNA 治疗药物的内在毒性和传递介导毒性的整体分析。
Adv Drug Deliv Rev. 2023 Oct;201:115052. doi: 10.1016/j.addr.2023.115052. Epub 2023 Aug 9.
7
Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes.利用 siRNA/VIPER 复合物抑制肺部的 SARS-CoV-2 复制。
J Control Release. 2022 May;345:661-674. doi: 10.1016/j.jconrel.2022.03.051. Epub 2022 Mar 29.
8
Basic Research on Tendon Repair: Strategies, Evaluation, and Development.肌腱修复的基础研究:策略、评估与进展
Front Med (Lausanne). 2021 Jul 28;8:664909. doi: 10.3389/fmed.2021.664909. eCollection 2021.
9
siRNA Therapeutics against Respiratory Viral Infections-What Have We Learned for Potential COVID-19 Therapies?小干扰 RNA 治疗呼吸道病毒感染——对潜在的 COVID-19 疗法有何启示?
Adv Healthc Mater. 2021 Apr;10(7):e2001650. doi: 10.1002/adhm.202001650. Epub 2021 Jan 27.
10
Advances in nanotechnology and asthma.纳米技术与哮喘的进展
Ann Transl Med. 2019 Apr;7(8):180. doi: 10.21037/atm.2019.04.62.